PAA 2.50% 20.5¢ pharmaust limited

Ann: Trading Halt, page-15

  1. 337 Posts.
    lightbulb Created with Sketch. 34
    From Proactive..... put on this thread in case you missed it.

    PharmAust Limited (ASXAA) has some interesting news on the horizon in the form of results in its human clinical trial.

    The ASX has granted the company a trading halt to prepare, with its shares placed in pre-open.

    Last week the company announced that it has completed the treatment of two canine patients with PPL-1 in combination with Carboplatin, one of the “standard of care” chemotherapy drugs used in both human and veterinary anticancer medicine.

    Neither dog suffered any adverse events despite the fact they both had progressive, advanced cancers and few treatment options.

    The halt will last until the earlier of an announcement being made to the market, or the opening of trade on Friday 24th July 2015.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.